COLCINE, PHARMACOR COLCHICINE (Pharmacor Pty Ltd)
Product name
COLCINE, PHARMACOR COLCHICINE
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
149 (255 working days)
Active ingredients
colchicine
Registration type
New generic medicine
Indication
Relief of pain in acute gout. COLCINE, PHARMACOR COLCHICINE (tablet) should not be used unless NSAIDS are contraindicated, or have been used and found to lack analgesic efficacy or to have unacceptable side effects in the individual patient.
COLCINE, PHARMACOR COLCHICINE is not an analgesic and does not provide relief from other types of pain.
Registration process
First generic
First approval of a medicine that contains the same active ingredient as and is bioequivalent to an existing medicine